Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W G Powderly

Showing results (101-110 of 128) with videos related to

Pageof 13
Sort By:
HIV Medicine|December 21, 2007
Post-exercise heart rate recovery in HIV-positive individuals on highly active antiretroviral therapy. Early indicator of cardiovascular disease?W T Cade, D N Reeds, S Lassa-Claxton, et al.
American Journal of Physiology. Endocrinology and Metabolism|August 25, 2005
Alterations in liver, muscle, and adipose tissue insulin sensitivity in men with HIV infection and dyslipidemiaD N Reeds, K E Yarasheski, L Fontana, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 19, 2000
Sex differences in nevirapine rashS J Bersoff-Matcha, W C Miller, J A Aberg, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|July 27, 1999
Insulin resistance in HIV protease inhibitor-associated diabetesK E Yarasheski, P Tebas, C Sigmund, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 19, 2000
Practice guidelines for the management of cryptococcal disease. Infectious Diseases Society of AmericaM S Saag, R J Graybill, R A Larsen, et al.
AIDS (London, England)|June 15, 2000
Impact of protease inhibitor therapy on HIV-related oropharyngeal candidiasisJ R Arribas, S Hernández-Albujar, J J González-García, et al.
The New England Journal of Medicine|December 7, 1995
A preliminary study of ritonavir, an inhibitor of HIV-1 protease, to treat HIV-1 infectionM Markowitz, M Saag, W G Powderly, et al.
The New England Journal of Medicine|March 16, 1995
A randomized trial comparing fluconazole with clotrimazole troches for the prevention of fungal infections in patients with advanced human immunodeficiency virus infection. NIAID AIDS Clinical Trials GroupW G Powderly, D Finkelstein, J Feinberg, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 1, 1993
Guidelines for the design and conduct of AIDS clinical trials. AIDS Clinical Trials GroupD J Cotton, W G Powderly, J Feinberg, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|February 1, 1993
Symptomatic cytomegalovirus infection in renal transplant recipients given either Minnesota antilymphoblast globulin (MALG) or OKT3 for rejection prophylaxisT C Bailey, W G Powderly, G A Storch, et al.
Pageof 13

Showing results (101-110 of 128) with videos related to

Sort By:
Pageof 13
HIV Medicine|December 21, 2007
Post-exercise heart rate recovery in HIV-positive individuals on highly active antiretroviral therapy. Early indicator of cardiovascular disease?W T Cade, D N Reeds, S Lassa-Claxton, et al.
American Journal of Physiology. Endocrinology and Metabolism|August 25, 2005
Alterations in liver, muscle, and adipose tissue insulin sensitivity in men with HIV infection and dyslipidemiaD N Reeds, K E Yarasheski, L Fontana, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 19, 2000
Sex differences in nevirapine rashS J Bersoff-Matcha, W C Miller, J A Aberg, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|July 27, 1999
Insulin resistance in HIV protease inhibitor-associated diabetesK E Yarasheski, P Tebas, C Sigmund, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 19, 2000
Practice guidelines for the management of cryptococcal disease. Infectious Diseases Society of AmericaM S Saag, R J Graybill, R A Larsen, et al.
AIDS (London, England)|June 15, 2000
Impact of protease inhibitor therapy on HIV-related oropharyngeal candidiasisJ R Arribas, S Hernández-Albujar, J J González-García, et al.
The New England Journal of Medicine|December 7, 1995
A preliminary study of ritonavir, an inhibitor of HIV-1 protease, to treat HIV-1 infectionM Markowitz, M Saag, W G Powderly, et al.
The New England Journal of Medicine|March 16, 1995
A randomized trial comparing fluconazole with clotrimazole troches for the prevention of fungal infections in patients with advanced human immunodeficiency virus infection. NIAID AIDS Clinical Trials GroupW G Powderly, D Finkelstein, J Feinberg, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 1, 1993
Guidelines for the design and conduct of AIDS clinical trials. AIDS Clinical Trials GroupD J Cotton, W G Powderly, J Feinberg, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|February 1, 1993
Symptomatic cytomegalovirus infection in renal transplant recipients given either Minnesota antilymphoblast globulin (MALG) or OKT3 for rejection prophylaxisT C Bailey, W G Powderly, G A Storch, et al.
Pageof 13